AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 278 filers reported holding AVANOS MED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $251,294 | -33.5% | 12,428 | -16.0% | 0.00% | – |
Q2 2023 | $378,135 | -55.6% | 14,794 | -48.3% | 0.00% | – |
Q1 2023 | $851,308 | +52.0% | 28,625 | +11.4% | 0.00% | – |
Q3 2022 | $560,000 | +128.6% | 25,707 | +251.9% | 0.00% | – |
Q1 2022 | $245,000 | -61.8% | 7,305 | -60.6% | 0.00% | – |
Q4 2021 | $642,000 | +189.2% | 18,518 | +203.6% | 0.00% | – |
Q2 2021 | $222,000 | -89.1% | 6,100 | -86.3% | 0.00% | – |
Q4 2020 | $2,044,000 | +325.8% | 44,550 | +208.2% | 0.00% | – |
Q3 2020 | $480,000 | +0.8% | 14,453 | -10.8% | 0.00% | – |
Q2 2020 | $476,000 | -73.8% | 16,209 | -76.0% | 0.00% | – |
Q1 2020 | $1,816,000 | +28.1% | 67,447 | +60.4% | 0.00% | – |
Q4 2019 | $1,418,000 | +3.7% | 42,058 | +15.2% | 0.00% | – |
Q3 2019 | $1,368,000 | -68.5% | 36,523 | -63.3% | 0.00% | – |
Q2 2019 | $4,345,000 | +348.9% | 99,590 | +338.7% | 0.00% | – |
Q1 2019 | $968,000 | +35.0% | 22,700 | +41.9% | 0.00% | – |
Q4 2018 | $717,000 | -89.2% | 16,000 | -83.5% | 0.00% | -100.0% |
Q3 2018 | $6,631,000 | – | 96,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
S.A. Mason LLC | 6,527 | $299,000 | 0.25% |